top cx logo
cx logo
Explorearrow down
search icon
Explore
arrow down

French Covid nasal vaccine could be more effective than jabs

Researchers say it would reinforce the body’s mucus defences enabling the body to block the virus before it gains entry to the body

Nasal vaccines stimulate the body’s mucus defences Pic: WESTOCK PRODUCTIONS / Shutterstock

Nasal vaccines may be used to fight against Covid in the future, as French research bodies work to develop a way of optimising the nose’s mucus defences against the virus. 

Teams from the Institut Pasteur and French laboratory Theravectys began working on a vaccine administered through the nose and without a needle because the protection offered by intramuscular injections can only go so far. 

“mRNA vaccines [such as Pfizer and Moderna] are a small miracle, but they have their limits,” Éric Tartour, immunology professor at the Georges-Pompidou hospital in Paris, told Ouest-France

This is because “they do not produce local immunity. You can be vaccinated but still infected by the virus, which will proliferate in your nasal mucus. And you can pass it on, even if you are asymptomatic,” he added. 

This is because traditional vaccines only lead to the generation of antibodies in the blood.

A nasal vaccine would aim to reinforce the body’s mucus defences, which have their own antibodies called Immunoglobulin A (IgA). Stimulating this defence system would enable the body to block the Covid virus before it gained entry to the body, preventing not just serious illness but also the initial infection. 

A previous Covid infection does lead to the protection of IgA antibodies, but “we do not know how long they last,” Prof Tartour said. “That might depend on the severity of the infection and the viral load.” 

“If we want to stop the epidemic, which is a public health duty, we will need nasal vaccines,” Prof Tartour said. “As long as vaccines fail to prevent the transmission and therefore the spread of the virus, we will be under threat from new variants.” 

Pre-clinical studies of Theravectys’ nasal-administered vaccine have suggested strong efficacy, with the viral load being drastically reduced along with pulmonary inflammation and tissue injury. 

However, researchers are currently testing nasal vaccines to determine whether they would be effective against the Omicron variant. 

Of the 300 vaccines which are being developed worldwide in the fight against Covid, only around 20 can currently be administered nasally. 

“Manufacturers are not often in the habit of making vaccines in the form of a spray, even though a nasal spray against flu is available in the US,” Prof Tartour said.

He added that it is necessary to “invest more money in innovating vaccine research.”

Related articles 

France reduces time gap to get Covid booster jab to keep health pass

More leading scientists in France say Omicron could be good news

Covid France: Latest on Omicron, hospitals and a possible fourth dose

Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
See more popular articles
The Connexion Help Guides
featured helpguide
Income Tax in France 2022 (for 2021 income)*
Featured Help Guide
- Primarily aimed at Britons, covers pensions, rent, ISAs, shares, savings and interest - Overview of online declarations + step-by-step guide to the French printed forms - Includes updates given automatically after this year's site opened
Get news, views and information from France
You have 2 free subscriber articles left
Subscribe now to read unlimited articles and exclusive content
Already a subscriber? Log in now